| AstraZeneca AG - Lynparza 150 mg, Filmtabletten | | 66745 | | 02 | | Lynparza 150 mg | | Filmtabletten | | L01XK01 | | Olaparib | | 27.09.2018 | | |
| | Composition | | olaparibum 150 mg, copovidonum K 28, silica colloidalis anhydrica, mannitolum, natrii stearylis fumaras corresp. natrium 0.354 mg, Überzug: hypromellosum, macrogolum 400, E 171, E 172 (flavum), E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Olaparibum | 150 mg |
| | BAG: Active Agent | Dose |
|---|
| Olaparibum | 150 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Nigrum) | | | | Copovidonum K | 28 | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Mannitol | | | | Natrii Stearylis Fumaras | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
